AIS
JAZZ icon

AlphaOne Investment Services’s Jazz Pharmaceuticals JAZZ Stock Holding History

AlphaOne Investment Services’s Portfolio JAZZ Stock Details JAZZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-440
Closed -$59K – 464
2017
Q4 		$59K Buy
440
+80
+22% +$11.1K 0.02% 198
2017
Q3 		$53K Buy
+360
New +$54.4K 0.01% 200
2015
Q1 		– Sell
-2,476
Closed -$405K – 97
2014
Q4 		$405K Buy
2,476
+485
+24% +$80.5K 0.15% 77
2014
Q3 		$320K Buy
+1,991
New +$306K 0.1% 86

Other funds holding JAZZ

PI
Putnam Investments Boston, Massachusetts $75.7B AUM 34.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
SIG
Senator Investment Group New York $2.18B AUM 58.56% 1-Year Est. Return
TCIM
TIAA CREF Investment Management New York $141B AUM 14.18% 1-Year Est. Return
CCM
Cadian Capital Management New York $821M AUM 14.36% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return

AlphaOne Investment Services's JAZZ Position: Q1 2018 in Review

AlphaOne Investment Services sold out of Jazz Pharmaceuticals (JAZZ) in Q1 2018, closing a stake of 440 shares — an estimated $59K sold.

AlphaOne Investment Services first reported a position in JAZZ in Q3 2014 and held it in 4 quarters. The position peaked at $405K in Q4 2014. 323 funds tracked by Wall St. Rank hold JAZZ as of Q1 2018.

  • AlphaOne Investment Services reported no remaining Jazz Pharmaceuticals position as of Q1 2018 after selling out during the quarter.
  • AlphaOne Investment Services sold 440 Jazz Pharmaceuticals shares in Q1 2018, an estimated $59K.
  • AlphaOne Investment Services first reported a position in Jazz Pharmaceuticals in Q3 2014 and held it in 4 quarters.
  • AlphaOne Investment Services's Jazz Pharmaceuticals position peaked at $405K in Q4 2014.
  • 323 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q1 2018.

Based on AlphaOne Investment Services's 13F filing for Q1 2018, filed 14 May 2018.